Abstract

This report describes our experiences of implementing a clinical genetics-coordinated service in our region to allow improved access to BRCA1/BRCA2 testing for epithelial ovarian cancer patients. We describe the GTEOC research study which informed the design of our regional NHS service, as well as local influences and general drivers for change which led us to offer this service. We hope that this description of our experiences of implementation may be useful for other providers considering setting up such a service for patients in their region.

With the aim of highlighting the benefits of the GTEOC approach for other service providers who may consider implementing this within their own region, this report, produced by Cambridge University Hospitals NHS Foundation Trust and the PHG Foundation, describes the broader context of genetic testing and mainstreaming initiatives, the findings from the GTEOC research study, and the implementation of the NHS GTEOC service within the East Anglia region.